9 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34651438 | Insights into the structure and drug design of benzimidazole derivatives targeting the epidermal growth factor receptor (EGFR). | 2021 Oct 15 | 5 |
2 | 31009910 | Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors. | 2019 Jul 1 | 1 |
3 | 29571113 | Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. | 2018 Aug | 1 |
4 | 27987485 | Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors. | 2017 Jan 27 | 2 |
5 | 26878127 | Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent. | 2016 Apr | 1 |
6 | 25766325 | A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells. | 2015 Mar 12 | 1 |
7 | 25844392 | Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole. | 2014 Apr 9 | 2 |
8 | 22564276 | Novel benzimidazole analogs as inhibitors of EGFR tyrosine kinase. | 2012 Oct | 1 |
9 | 21724404 | Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors. | 2011 Aug 1 | 3 |